Our Pricing

Understanding Wegovy Injection Cost in the UK

Researching wegovy injection cost uk options? At Cured Pharmacy, Wegovy (semaglutide) starts from £79.00 with transparent upfront pricing, free clinical consultation by UK prescribers, and discreet next-day delivery. Our WEIGHTLOSSNEW discount code saves you £79.00 off your first order, making clinically-proven weight management more accessible.

What Affects Wegovy Injection Cost in the UK?

The wegovy injection cost uk varies based on your prescribed dose strength and treatment duration. Wegovy is available in five escalating doses (0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg), with patients typically starting at the lowest dose and titrating upward over 16-20 weeks to minimise gastrointestinal side effects [1]. Each pen delivers four weekly injections, and your UK prescriber determines the appropriate dose based on your clinical response and tolerability.

At Cured Pharmacy, we guarantee the lowest prices in the UK with complete price transparency before you begin your consultation. Unlike traditional pharmacies that only reveal costs after assessment, our pricing is displayed upfront at £79.00 per pen, reduced from the typical market rate. All prescription medications require online clinical assessment by a UK-registered prescriber, completed in under three minutes via our secure platform.

How Wegovy (Semaglutide) Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity [2]. Semaglutide mimics a natural gut hormone that regulates appetite and food intake by acting on areas of the brain that control hunger signals.

In the landmark STEP 1 clinical trial, participants using semaglutide 2.4mg achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [2]. Importantly, 86.4% of semaglutide-treated patients achieved at least 5% weight loss, and 69.1% achieved at least 10% weight loss, demonstrating consistent efficacy across diverse patient populations [2].

Clinical Evidence Supporting Wegovy

The STEP clinical trial programme enrolled over 4,500 participants across five major studies, establishing semaglutide as one of the most rigorously evaluated weight management medications available in the UK [2][3]. Beyond weight reduction, trial participants experienced improvements in cardiovascular risk markers, including reductions in waist circumference, blood pressure, and HbA1c levels in those with prediabetes [3]. Your UK prescriber will review your complete medical history to determine whether Wegovy is clinically appropriate for your individual circumstances.

Wegovy vs Alternative Weight Loss Treatments

Several prescription weight loss treatments are licensed in the UK, each working through different mechanisms. Wegovy (semaglutide) is a once-weekly injectable GLP-1 receptor agonist that has demonstrated superior weight loss outcomes in head-to-head trials compared to earlier-generation treatments. Saxenda (liraglutide) is a daily injectable GLP-1 agonist that shares a similar mechanism but requires more frequent administration. Orlistat is an oral medication that works by blocking fat absorption in the digestive system, typically producing more modest weight reductions of 5-10% [4].

Mounjaro (tirzepatide) represents the newest class of weight management medication, functioning as a dual GIP/GLP-1 receptor agonist. In comparative trials, tirzepatide demonstrated greater average weight reduction than semaglutide, though both medications require ongoing treatment and lifestyle modifications for sustained results [5]. The choice between treatments depends on your medical history, treatment goals, injection frequency preference, and prescriber recommendation following clinical assessment.

Choosing the Right Treatment for You

Your UK prescriber will assess multiple factors when recommending a weight management medication, including your BMI, existing health conditions, previous treatment responses, and personal preferences regarding injection frequency. All GLP-1 medications require commitment to dietary and physical activity modifications for optimal results, as demonstrated in clinical trials where lifestyle intervention was a core component of treatment protocols [2][3]. At Cured Pharmacy, our clinical team provides personalised guidance throughout your treatment journey, with ongoing support available via phone on (+44) 116 4646009.

Using Your WEIGHTLOSSNEW Discount Code

Cured Pharmacy offers the WEIGHTLOSSNEW discount code to make clinically-proven weight management more affordable for UK patients. This code provides £79.00 off your first Wegovy order, reducing the starting cost and supporting your initial commitment to treatment. The discount applies automatically during checkout when you enter the code, and can be combined with our already-competitive pricing structure.

To redeem your discount, complete the free online clinical consultation, receive prescriber approval, and enter WEIGHTLOSSNEW at checkout before payment. The code is valid for first-time Wegovy patients at Cured Pharmacy and applies to all dose strengths subject to clinical appropriateness. Our transparent pricing model ensures you know the exact cost before beginning your consultation, with no hidden fees or surprise charges at any stage of the process.

What to Expect During Wegovy Treatment

Wegovy treatment follows a structured dose escalation schedule designed to improve gastrointestinal tolerability. Most patients begin with the 0.25mg dose for four weeks, then increase to 0.5mg for four weeks, followed by monthly increases to 1mg, 1.7mg, and finally the maintenance dose of 2.4mg [1]. This gradual titration significantly reduces the incidence of nausea, vomiting, and diarrhoea compared to starting at higher doses.

Common side effects reported in clinical trials include nausea (44% of participants), diarrhoea (30%), vomiting (24%), and constipation (24%), with most symptoms being mild to moderate and diminishing over time [2]. Serious side effects are rare but can include pancreatitis, gallbladder problems, and hypoglycaemia in patients taking certain diabetes medications. Your UK prescriber will review contraindications including personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 before prescribing.

Wegovy is administered once weekly via subcutaneous injection in the abdomen, thigh, or upper arm. Each pre-filled pen is designed for single use and should be stored in the refrigerator between 2°C and 8°C until use. Patients typically inject on the same day each week, and if a dose is missed, it should be administered within five days or skipped entirely to maintain the weekly schedule [1].

Monitoring Your Progress

Clinical guidelines recommend regular monitoring during Wegovy treatment to assess efficacy and tolerability. NICE guidance suggests evaluating weight loss response after 6-12 months, with continuation dependent on achieving at least 5% body weight reduction alongside improvements in weight-related comorbidities [6]. Your prescriber may recommend periodic check-ins to review side effects, adjust dosing if needed, and provide ongoing support for dietary and activity modifications that enhance treatment outcomes.

How to Order Wegovy from Cured Pharmacy

Ordering Wegovy from Cured Pharmacy is straightforward and fully compliant with UK pharmacy regulations. Begin by completing our free online consultation, which takes under three minutes and covers your medical history, current medications, and weight management goals. Our UK-registered prescribers review your submission within hours, and if clinically appropriate, issue a prescription that our pharmacy team dispenses using genuine UK-licensed Wegovy pens.

All orders are dispatched in 100% discreet packaging with next-day delivery options available across the UK. As a GPhC-registered pharmacy (registration number 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073), we adhere to the highest standards of patient safety and medication quality. Every Wegovy pen is sourced directly from licensed UK wholesalers and stored in temperature-controlled conditions to maintain efficacy.

Your prescription is valid for ongoing treatment, and we offer convenient repeat ordering with reminders to ensure continuity of care. Our clinical team is available to answer questions about administration technique, side effect management, or treatment adjustments throughout your weight loss journey. Contact us on (+44) 116 4646009 or visit curedpharmacy.com to begin your assessment today.

Scientific References

1. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
3. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0
4. National Institute for Health and Care Excellence. (2022). Obesity: identification, assessment and management (CG189). NICE Clinical Guideline. https://www.nice.org.uk/guidance/cg189
5. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
6. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity (TA875). NICE Technology Appraisal Guidance. https://www.nice.org.uk/guidance/ta875

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is indicated for weight management in adults with a BMI ≥30 kg/m², or ≥27 kg/m² with weight-related comorbidities, alongside reduced calorie diet and increased physical activity.